Basic Information
Nebivolol
31722-586
Regulatory Information
31722-586
ANDA203825
C73584
January 31, 2024
USA
These highlights do not include all the information needed to use NEBIVOLOL TABLETS safely and effectively. See full prescribing information for NEBIVOLOL TABLETS. NEBIVOLOL tablets, for oral use Initial U.S. Approval: 2007
HUMAN PRESCRIPTION DRUG LABEL
2
Company Information
826774775
Active Ingredients
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
CROSCARMELLOSE SODIUM
Code: M28OL1HH48
Class Code: IACT
HYPROMELLOSE 2910 (5 MPA.S)
Code: R75537T0T4
Class Code: IACT
FD&C YELLOW NO. 6
Code: H77VEI93A8
Class Code: IACT
LACTOSE MONOHYDRATE
Code: EWQ57Q8I5X
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
MICROCRYSTALLINE CELLULOSE 102
Code: PNR0YF693Y
Class Code: IACT
Active Moieties
NEBIVOLOL
Code: 030Y90569U